Panasonic adds "nanoe X" air cleaning technology to PACi and VRF ranges

12th March 2022

Panasonic Panasonic is adding its nanoe X air cleaning technology to its PACi and VRF ranges of air conditioners.

The nanoe X generators clean and deodorise the air by producing nano-sized hydroxyl radicals (also known as OH radicals). These have been shown to inhibit the growth of certain pollutants such as allergens, bacteria, viruses, moulds, odours and certain hazardous substances, by breaking them down and inhibiting their unpleasant effects.

The technology comes as standard in Panasonic’s residential Etherea air conditioning range and the floor console units, and is now being expanded to its PACi and VRF commercial range, including the 90×90 cassette, new duct units and floor console units over the coming months.

Made with titanium and said to be maintenance free, the first nanoe device was developed by Panasonic in 2003 and has been radically improved since. The effectiveness of nanoe X technology is said to have been independently verified and tested by international third-party laboratories in Germany, Denmark, Malaysia and Japan.

Indeed, a leading viral testing organisation in Germany is said to have verified the inhibitory effect of Panasonic’s nanoe X air cleaning technology on the novel coronavirus (SARS-CoV-2). The comparative verification was conducted in a 45 litre test space containing the novel coronavirus (SARS-CoV-2) with and without exposure to nanoe X. Over 99.99% of virus activity was said to have been inhibited within 2 hours.

Latest Updates

Panasonic adds "nanoe X" air cleaning technology to PACi and VRF ranges

12th March 2022

Panasonic is adding its nanoe X air cleaning technology to its PACi and VRF ranges of air conditioners.

Panasonic has verified the inhibitory effect of the hydroxyl radicals contained in water on the novel coronavirus (SARS-CoV-2).

03rd August 2020

Panasonic has verified the inhibitory effect of the hydroxyl radicals contained in water on the novel coronavirus (SARS-CoV-2).

View All News